Hanson & Doremus Investment Management Buys 940 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hanson & Doremus Investment Management lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 213.6% in the first quarter, according to its most recent filing with the SEC. The fund owned 1,380 shares of the medical equipment provider's stock after acquiring an additional 940 shares during the period. Hanson & Doremus Investment Management's holdings in Intuitive Surgical were worth $683,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. Hurley Capital LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth approximately $28,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical during the fourth quarter valued at approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Finally, Global Financial Private Client LLC lifted its holdings in shares of Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now owns 6,371 shares in the company, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Mark Brosius sold 215 shares of Intuitive Surgical stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $549.06, for a total value of $118,047.90. Following the completion of the sale, the senior vice president now owns 1,768 shares of the company's stock, valued at $970,738.08. The trade was a 10.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Citigroup restated a "buy" rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Robert W. Baird dropped their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Finally, Evercore ISI lowered their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $588.95.

Intuitive Surgical Trading Up 1.3%

Intuitive Surgical stock traded up $6.86 on Monday, hitting $519.04. 1,513,774 shares of the stock traded hands, compared to its average volume of 1,675,177. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The firm has a market cap of $186.03 billion, a P/E ratio of 80.97, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67. The business's fifty day simple moving average is $526.57 and its 200 day simple moving average is $538.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the previous year, the company posted $1.50 earnings per share. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.